Seres Therapeutics, Inc. (MCRB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 131.82M |
| Enterprise Value | 169.02M |
| P/E Ratio | -0.74 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 9.34 |
| Price/Book Ratio | 0.49 |
| Enterprise/Revenue | 31.14 |
| Enterprise/EBITDA | -1.31 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -11.93 |
| Operating Margin | -44.63 |
AD
Management Effectiveness
| Return On Assets | -0.22 |
| Return On Equity | -0.6 |
Income Statement
| Revenue | 789,000 |
| Revenue/Share | 0.2 |
| Gross Profit | -3.34M |
| EBITDA | 9.83M |
| Net Income | 5.7M |
| Diluted EPS | 0.64 |
Balance Sheet
| Total Cash | 15.59M |
| Total Cash/Share | 1.62 |
| Total Debt | 56.64M |
| Total Debt/Equity | 1.64 |
| Current Ratio | 2.11 |
| Book Value Per Share | 3.58 |
Price History
| 52-Week Change | -88.39 |
| 52-Week High | 29.98 |
| 52-Week Low | 1.68 |
| Moving Average 50 Days | 3.62 |
| Moving Average 200 Days | 7.11 |
Statistics
| Average Volume | 69,278 |
| Shares Outstanding | 9.94M |
| % Held by Institutions | 23.9 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | April 22, 2025 |
AD
